Clinical Characteristics of Coronary Drug-Eluting Stent Fracture: Insights from a Two-Center DES Registry

Kyung-Woo PARK; Jin-Joo PARK; In-Ho CHAE; Jae-Bin SEO; Han-Mo YANG; Hae-Young LEE; Hyun-Jae KANG; Young-Seok CHO; Tae-Jin YEON; Woo-Young CHUNG; Bon-Kwon KOO; Dong-Ju CHOI; Byung-Hee OH; Young-Bae PARK; Hyo-Soo KIM.
Journal of Korean Medical Science ; : 53-58, 2011.
Artículo en Inglés | WPRIM | ID: wpr-137393

Documentos relacionados

  1. Clinical characteristics of coronary drug-eluting stent fracture: insights from a two-center des registry.
  2. Thrombus-related focal in-stent restenosis after everolimus-eluting stent implantation.
  3. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis.
  4. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
  5. Clinical outcomes of an ultrathin-strut sirolimus-eluting stent in all-comers population: Thailand Orsiro registry.
  6. First report of a novel polymer-free dual-drug eluting stent in de novo coronary artery disease: results of the first in human BICARE trial.
  7. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
  8. Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries.
  9. Randomized comparison of the efficacy and safety of zotarolimus-eluting stents vs. sirolimus-eluting stents for percutaneous coronary intervention in chronic total occlusion--CAtholic Total Occlusion Study (CATOS) trial.
  10. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.